6-aminophenanthridine has been researched along with Oculopharyngeal Dystrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbezier, N; Bidet, Y; Blondel, M; Buttstedt, A; Chartier, A; Galons, H; Schwarz, E; Simonelig, M; Voisset, C | 1 |
Blondel, M; Saupe, SJ; Voisset, C | 1 |
1 review(s) available for 6-aminophenanthridine and Oculopharyngeal Dystrophy
Article | Year |
---|---|
The various facets of the protein-folding activity of the ribosome.
Topics: Guanabenz; Molecular Chaperones; Muscular Dystrophy, Oculopharyngeal; Phenanthridines; Prion Diseases; Protein Biosynthesis; Protein Folding; Proteins; Ribosomes; RNA, Ribosomal | 2011 |
1 other study(ies) available for 6-aminophenanthridine and Oculopharyngeal Dystrophy
Article | Year |
---|---|
Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.
Topics: Animals; Drosophila; Guanabenz; Larva; Muscular Dystrophy, Oculopharyngeal; Phenanthridines; Phenotype; Poly(A)-Binding Protein II; Prion Diseases; Protein Folding; RNA, Ribosomal | 2011 |